Infarct Size as Assessed by Peak Enzyme Levels is Reduced in Patients Who Are Using Angiotensin-Converting Enzyme Inhibitors at the Onset of Infarction

By Landmark K.   Aursnes I.  

Clinical Drug Investigation, Vol. 20, Iss. 6, 2000-12 ,pp. : 415-423

Adis International

Access to resources Recommend Favorite

Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

By Lexis Chris   Wieringa Wouter   Hiemstra Bart   Deursen Vincent   Lipsic Erik   Harst Pim   Veldhuisen Dirk   Horst Iwan  

Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite

Statin-induced myopathy: minimize the risk and manage according to symptoms and creatine kinase levels

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 10, 2010-10 ,pp. : 21-23

Adis International

Access to resources Recommend Favorite

In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia

By Huang J.-Q.   Radinovic S.   Rezaiefar P.   Black S.C.  

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease

By Rosendorff Clive  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1535-1541

Informa Healthcare

Access to resources Recommend Favorite